NCT03427294 is a clinical trial of Delphi study in Lumbar Spine Degeneration, sponsored by Universitaire Ziekenhuizen KU Leuven.

Who is sponsoring NCT03427294?

NCT03427294 is sponsored by Universitaire Ziekenhuizen KU Leuven.

What drugs are being tested in NCT03427294?

Interventions in NCT03427294: Delphi study.

What condition does NCT03427294 study?

NCT03427294 studies Lumbar Spine Degeneration, Physical Disability, Surgery.

Is NCT03427294 still recruiting?

NCT03427294 is currently completed. Last updated 27 January 2023.

Last reviewed 2023-01-27 · How we verify

NCT03427294

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Delphi Study on Rehabilitation Following Lumbar Arthrodesis

Completed Last updated 27 January 2023

What this trial tests

trial testing Delphi study in Lumbar Spine Degeneration in 31 participants. Completed in 31 December 2019.

Timeline

3 January 2018

Primary endpoint
31 December 2019

31 December 2019

Quick facts

Lead sponsor	Universitaire Ziekenhuizen KU Leuven
Status	Completed
Study type	OBSERVATIONAL
Enrollment	31
Start date	3 January 2018
Primary completion	31 December 2019
Estimated completion	31 December 2019
Sites	1 location across Belgium

Drugs / interventions tested

Delphi study

Conditions studied

Lumbar Spine Degeneration — all drugs for Lumbar Spine Degeneration →
Physical Disability — all drugs for Physical Disability →
Surgery — all drugs for Surgery →

Sponsor

Universitaire Ziekenhuizen KU Leuven — full company profile →

Who can join

18 and older, any sex, with Lumbar Spine Degeneration or Physical Disability. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Delphi study on perioperative rehabilitation after single and double level lumbar arthrodesis.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Best practice rehabilitation pathway for the management of single and double-level lumbar fusion surgery: a modified Delphi Study.
Bogaert L, Thys T, Depreitere B, VAN Wambeke P, et al · · 2023 · cited 8× · PMID 36988564 · DOI 10.23736/s1973-9087.23.07735-3
Qualitative study exploring the views of patients and healthcare providers on current rehabilitation practices after lumbar fusion surgery.
Thys T, Bogaert L, Dankaerts W, Depreitere B, et al · · 2024 · cited 6× · PMID 38816040 · DOI 10.1136/bmjopen-2023-077786

Verify or expand the search:

Other trials of Delphi study

Trials testing the same drug.

NCT07173660 — Consensus Statements on Deep Brain Stimulation in Patients With Parkinson's Disease · not yet recruiting
NCT06916598 — Consensus Statements on Definition, Components and Grading of Postoperative Pulmonary Complications · enrolling by invitation
NCT05422872 — Delphi Study on Psychological Safety Competencies in Healthcare Training Curricula · completed

Other recruiting trials for Lumbar Spine Degeneration

Currently open trials in the same condition.

NCT05452694 — OpalGenix- Personalized Postoperative Pain Management Following Lumbar Spinal Fusion and Decompression Surgery in Adults · recruiting
NCT05438719 — MOTUS Total Joint Replacement Investigational Device Exemption Study · NA · active not recruiting
NCT05746143 — The Effect of Zolpidem on Outcomes Following Lumbar Spine Fusion · Phase 4 · recruiting
NCT04823858 — 3Spine Lumbar Fusion Real World Evidence Study · active not recruiting
NCT05945550 — Comparison of Complication Rates Between Initial and Re-operative Anterior Lumbar Interbody Fusion Surgery: Is There a D · active not recruiting

Other Universitaire Ziekenhuizen KU Leuven trials

Trials by the same sponsor.

NCT06831955 — LifEStyle Intervention to Enhance Efficacy of Neoadjuvant Therapy in Patients With Triple Negative Breast Cancer · Phase 2 · recruiting
NCT07356505 — Efficacy and Safety of Micra AV2 Transcatheter Pacing System · NA · recruiting
NCT07286968 — Gastro-Intestinal Digestion and Physiology After Bariatric Surgery · recruiting
NCT06962137 — Phase II RAINSPOT: Zolbetuximab-Paclitaxel-Ramucirumab for CLDN18.2 Positive Gastro-esophageal Cancer · Phase 2 · recruiting
NCT07270536 — Accelerated Pacing and Cardiac Filling Pressures During Exercise in Patients With Heart Failure With Preserved Ejection · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03427294 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Universitaire Ziekenhuizen KU Leuven
Last refreshed: 27 January 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03427294.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing